Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,506 | 24,074 | 25,254 | 25,600 | 23,081 |
| Other current assets | 0 | 997 | 186 | 277 | 268 |
| TOTAL | $93,994 | $25,071 | $25,440 | $25,877 | $23,349 |
| Non-Current Assets | |||||
| PPE Net | 11 | 12 | 13 | 33 | 47 |
| Other Non-Current Assets | 295 | 316 | 45 | 67 | 90 |
| TOTAL | $306 | $328 | $58 | $100 | $137 |
| Total Assets | $94,300 | $25,399 | $25,498 | $25,977 | $23,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 911 | 465 | 416 | 608 | 453 |
| Accrued Expenses | 802 | 638 | 839 | 459 | 835 |
| Other current liabilities | 94 | 7 | 14 | 11 | 9 |
| TOTAL | $1,865 | $1,168 | $1,314 | $1,145 | $1,387 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 235 | 258 | 0 | 0 | 0 |
| TOTAL | $235 | $258 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,100 | $1,426 | $1,314 | $1,145 | $1,387 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,898 | 25,579 | 24,919 | 24,780 | 24,730 |
| Common Shares | 35 | 26 | 25 | 25 | 22 |
| Retained earnings | -174,921 | -172,303 | -170,873 | -169,737 | -168,587 |
| TOTAL | $92,200 | $23,973 | $24,184 | $24,832 | $22,099 |
| Total Liabilities And Equity | $94,300 | $25,399 | $25,498 | $25,977 | $23,486 |